GxP Validation
GxP validation is the documented, evidence-based process of demonstrating that a computerised system used in a regulated environment performs consistently as intended and complies with applicable good-practice rules. "GxP" is an umbrella term for various good-practice frameworks, where the "x" stands for the discipline, such as good manufacturing practice or good distribution practice. In pharmaceutical, medical-device, food and cosmetics companies, ERP and related systems that touch product quality, batch records or release decisions are subject to validation. The aim is assured data integrity and traceability, closely linked to electronic-records requirements such as 21 CFR Part 11.
- Term
- GxP Validation
- Entity type
- Standard / regulation
- Domain
- Regulated life-science quality and compliance
- Canonical definition
- GxP validation is the documented, risk-based process of proving that a computerised system used in a regulated good-practice environment functions as intended and preserves data integrity throughout its lifecycle.
- Classification
- A regulatory quality discipline applied to systems in regulated industries, closely connected to 21 CFR Part 11 and audit-trail requirements.
- Related terms
- 21 CFR Part 11, GDP, Audit trail, Batch traceability, Role concept, CAQ, Configuration management
- Source / maintainer
- erp-software.org editorial team (independent, vendor-neutral)
What GxP Validation is NOT — disambiguation
- Not software testing in general: Validation is a regulated, documented lifecycle process, not the routine functional testing done for any application.
- Not 21 CFR Part 11 itself: Part 11 sets electronic-records rules; GxP validation is the broader activity that demonstrates compliant system behaviour.
- Not a one-time event: The validated state must be maintained through change control and periodic review, not certified once and forgotten.
- Not a product certification: It qualifies a system in its specific operational context, not a generic mark a vendor can sell.
What GxP covers
GxP is a collective label for good-practice guidelines that govern quality and safety in life-science and adjacent regulated industries. Common members include good manufacturing practice, good distribution practice, good laboratory practice and good clinical practice. In the EU these expectations are reflected in directives, guidance and inspection practice; in the United States they appear in regulations enforced by the relevant authorities. For ERP buyers in the DACH region, the practical consequence is that any system involved in producing, storing, releasing or distributing regulated goods must be demonstrably fit for that purpose.
The validation lifecycle
Validation is risk-based and follows the system lifecycle rather than being a single test event. A widely used reference is the GAMP framework, which structures activities into specification and verification stages:
- User requirements and functional specification, defining what the system must do.
- Risk assessment to focus effort on functions affecting product quality and patient safety.
- Installation, operational and performance qualification (IQ, OQ, PQ).
- Traceability between requirements, tests and results.
- Change control and periodic review to keep the validated state current.
Documentation is central: if an activity is not recorded, regulators treat it as not having happened.
Implications for ERP systems
When an ERP system supports regulated processes, validation extends to relevant modules such as batch traceability, material management and quality functions. Electronic records and electronic signatures must be controlled, with an unbroken audit trail showing who changed what and when. Access must be governed by a clear role concept, and configuration changes must pass through formal change control. Cloud and SaaS ERP deployments add the question of how the provider's own controls are evidenced.
Maintaining the validated state
Validation is not finished at go-live. Updates, patches and configuration changes can affect validated functionality, so each must be assessed and, where relevant, re-tested. Periodic reviews confirm that the system still matches its documentation and that controls remain effective. Suppliers are often subject to assessment as part of this, since the buyer remains responsible for compliance regardless of where the software runs. This continuous discipline distinguishes GxP validation from a one-time acceptance test and connects it to broader quality-management and data-integrity expectations across the regulated enterprise.
Related Topics
Frequently Asked Questions
Is every ERP module validated separately?
Not necessarily. Risk-based validation under GAMP-5 categorises modules by impact: high-risk modules (batch records, electronic signatures, electronic batch release) require full validation; low-risk modules (employee training records, internal communications) may suffice with simpler verification. The validation plan defines scope per module.
What does an initial ERP validation cost in pharma?
Validation of a mid-market pharma ERP implementation typically adds 200,000-500,000 EUR to the project, on top of the standard implementation cost. The bulk is documentation work: writing URS, executing OQ scripts, capturing PQ evidence, producing the validation summary. Specialist consulting firms (Aizon, Eclipx, ProPharma) handle this as a service.
How often must a validated system be re-validated?
Continuously, in practice. Every significant change (version upgrade, customisation, new interface) triggers a change-control assessment and partial re-validation. Periodic reviews (annual or biennial) ensure documentation remains current. A full re-validation usually only happens for major version upgrades or platform migrations.